PENGARUH ASAP ROKOK TERHADAP KUALITAS HIDUP TOTAL PENDERITA RINITIS ALERGI PERSISTEN
https://doi.org/10.35974/jsk.v2i1.235
Keywords:
libraries, publishing, research servicesAbstract
ABSTRAK
Pendahuluan: Pengaruh asap rokok pada penderita Rinitis Alergi Persisten (RAP) yang prevalensinya semakin meningkat di Indonesia belum mendapat perhatian untuk diteliti, meskipun jumlah penduduk yang merokok semakin bertambah. Tujuan: Menganalisis hubungan asap rokok “side-stream” (SS) dengan perubahan kualitas hidup (KH) total penderita Rinitis Alergi Persisten (RAP). Metode: Penelitian ini adalah dengan desain kasus kontrol, dimana 63 penderita RAP sedang-berat yang dibuktikan dengan tes alergi dibagi menjadi kelompok perlakuan (32) dan kontrol (31) secara acak. 32 penderita RAP dipaparkan dengan asap rokok (SS) dari 5 batang rokok selama 2 jam dalam suatu ruangan. Seluruh responden diminta mengisi kuesioner kualitas hidup dari Juniper’s RQLQ. Hasil: KH total antara kelompok perlakuan dengan kontrol tidak berbeda bermakna. KH total yang terpapar asap rokok setiap hari berbeda bermakna. Diskusi: Asap rokok yang dipaparkan pada penderita RAP tidak menyebabkan perubahan kualitas hidup.
ABSTRACT
Introduction: The effect of cigarette smoke on Persistent Allergic Rhinitis patients (RAP) prevalence is increasing in Indonesia. Although the number of people who smoke is increasing yet it has not received attention for examination. Objective: To analyze the relationship between cigarette smoking "side-stream" (SS) with the change in total quality of life (TQL) among patients with Persistent Allergic Rhinitis (PAR). Method: This study is a case-control design, in which 63 patients with moderate-severe RAP evidenced by allergy tests are divided into treatment groups (32) and control (31) randomly. RAP 32 patients were exposed to cigarette smoke (SS) from 5 cigarettes for 2 hours in a room. All respondents were asked to fill out questionnaires quality of life of Juniper's RQLQ. Results: KH total between treatment groups was not significantly different with control. KH total exposed to secondhand smoke every day significantly different. Discussion: Cigarette smoke described in patients with RAP does not lead to changes in the quality of life.
Downloads
References
Abbas AK, Lichtman AH, Pillai A 2007. Cytokines. In: Cellular and Molecular Immunology. 6 th ed. Philadelphia : Elsevier, 2007.p.267-301
Achadi A, Soerojo W, Barber S 2004. The relevance and prospects of advancing tobacco control in Indonesia. Health Pol 72, 333-49
Biagini. JM,LeMaster GK, Ryan PH et al 2006. Environmental risk factors of rhinitis in early infancy. Pediatr Allergy Immunol ;17:278-284
Bousquet J, Bullinger M, Fayol C et al 1994. Assessment of quality of life patients with perennial allergic rhinitis with the French versions of the SF-36 health status questionnaire. J All Clin Immunol ; 94:182-8 (19)
Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica W, Durham Sl 2000. Position Paper; Concensus statement on the treatment of allergic rhinitis. Allergy ; 55:116-134.
De Beyer J, Yurekli AA 2000. Curbing the tobacco epidemic in Indonesia. Watching brief, east asia and the pacific region. May, 6: 1-9
Einhorn IN, 1975. Physiological and toxicological aspects of smoke produced during the combustion of polymeric materials. Environ Health Perspec; 11:163-89
Eisner MD, Blanc PD 2000. Environmental tobacco smoke and adult asthma. In : Watson RR, Witton M, ed. Environmental Tobacco Smoke. 1st ed. Florida : CRC Press LLC;p.81-106
HEI Air toxics Review Panel, 2007. Mobile-Source Air Toxics : A Critical Review of the Literature on Exposure and Health Effects. HEI special Report 16. Health Effects Institute, Boston, MA.
Hinwood AL, Rodriguez CM 2005. Potential health impacts associated with peat smoke : a review. Journal of the Royal Society of Western Australia, 88 :133-8
Janeway CA 2008. T Cell-Mediated Immunity. In : Janeway’s Immuno Biology. 7 th ed.New York, Garland Publishing; p.323-377
JiaLH, LiuZB, SunLJ, MillerSS, AmesBN, CotmanCW, LiuJK 2007. Acrolein, a Toxicant in Cigarette Smoke, Causes Oxidative Damage and Mitochondrial Dysfunction in RPE Cells : Protection by (R)-α-Lipoic acid. Invest Ophthalmol Vis Sci. 48(1) 339-48
Juniper EF1997. Measuring health-related quality of life in rhinitis. J All Clin Immunol ; 99:S742-9
Kehrer JP, Biswal SS 2000. The Molecular effects of Acrolein. Toxicological Sciences. 57, 6-15
Koppelman GH 2007. Gene-environment interaction in allergic disease : More questions, more answer. J All Clin Immunol ;120:1266-8
Lambert C, McCue J, Portas M, Quyang Y, Li JM, Rosano TG, Lazis A, Freed BM 2005. Acrolein in cigarette smoke inhibits T-cell responses. J Clin Immunol ; 116 :916-22
Lihong Jia, Zhongbo Liu, Lijuan Sun, Sheldon S. Miller, Bruce N. Ames, Carl W. Cotman, Jiakang Liu. Acrolein, a Toxicant in Cigarette Smoke, Causes Oxidative Damage and Mitochondrial Dysfunction in RPE Cells : Protection by (R) – α- Lipoic Acid. Invest Ophthalmol Vis Sci 48(1) : 339-348
Long SA, D’Antonio LL, Nathan RA et al 1996. Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope ; 106:1084-8
Madiadipoera T, Surachman S, Sumarman I, Boesoerie TS 2002. Parameter Keberhasilan Pengobatan Rintis Alergi. Otolaryngologica Indonesia : XXXII(3); 33-40
Mucha SM, deTenio M, Naclerio RM, Baroody FM 2006. Comparison of Montelukast and pseudoephedrine in the treatment of Allergic Rhinitis. Arch Otolaryngol Head Neck Surg. ;132, 164-72
Mullol J, Maurer M, Bousquet J 2008. Sleep and Allergic Rhinitis. J Investig Allergol Clin Immunol; 18 (6). 415-9
Navarro A, Colas C, Anton E, Conde J, Davila I, Dordal MT et al 2009. Epidemiology of allergic rhinitis in allergy consultation in Spain : Alergologica-2005. J Investig Allergol Immunol ,19(2) 7-13
Pawankar R, Mori S, Ozu C, Kimura S 2011. Overview on the pathomechanisms of allergic rhinitis. Asia Pac Allergy ; 1: 157-67
Pinto JM, Jeswani S 2010. Rhinitis in the geriatric population. Allergi, asthma & clinical immunology. ; 6,1-12
Quyang Y, Virasch N, Hao P,Aubrey MT, Mukerjee N, Blerer BE, Freed BM 2000. Supression of human IL-1β, IL-2, IFN-γ, and TNF-α production by cigarette smoke extracts. J All Clin Immunol ;106:280-7
Suprihati 2005. The Prevelence of Allergic rhinitis and its relation to some risk factors among 13-14 year old students in semarang, Indonesia Otolaryngologica Indonesiana : XXXV(2); 37-70
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Roy David Sarumpaet, Mohammad Juffrie, Suprihati ., Indwiani Astuti
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).